Core Viewpoint - The Hong Kong stock market experienced a significant surge in equity financing in 2025, with a total financing amount of HKD 6,122 billion, reflecting a year-on-year increase of 250.91%. The IPO market regained its global leading position, raising HKD 2,858 billion from 117 companies, a year-on-year growth of 224.24%. The outlook for 2026 remains positive, with expectations of continued high levels of IPO and refinancing activity, although growth rates may not match those of 2025 [2][10]. Group 1: Market Performance and Trends - The number of companies waiting for IPOs in Hong Kong has exceeded 300, indicating a robust market environment [1][8]. - Market consensus suggests that the active trend in Hong Kong's equity financing will persist, driven by favorable policies from the Hong Kong Stock Exchange, the return of Chinese concept stocks, and increasing demand for cross-border listings [2][10]. - As of January 15, 2026, there are 327 companies queued for listing, with nearly half being A-share companies, providing a solid foundation for market activity [3][11]. Group 2: International Capital Inflow - There has been a substantial return of international capital to the Hong Kong market, with participation rates from major international long-term funds rising to 85%-90% in IPO projects, compared to only 10%-15% at the beginning of 2024 [6][15]. - International investors are particularly interested in companies with clear business models, predictable profitability, and reasonable valuations, especially in sectors like AI and consumer goods [6][15]. Group 3: IPO Impact on Market Liquidity - The influx of quality IPOs is expected to attract more international capital, enhancing overall market activity rather than draining liquidity [4][12]. - Discussions around the potential pressure on the secondary market due to high IPO demand highlight the need to differentiate between structural issues and temporary phenomena [4][12]. - The performance of stocks post-IPO is influenced by various factors, including pricing, investor structure, and industry conditions, with a focus on the six-month period following the IPO for key investor unlocks [5][13]. Group 4: Future Outlook for IPOs - The IPO market in 2026 is anticipated to be driven by four main categories of companies: biotechnology firms, specialized technology companies (including AI and semiconductors), traditional industry upgrade representatives, and new consumer brands from mainland China [7][16]. - The biotechnology sector is expected to maintain its high growth trajectory, while other technology sectors are also poised for significant activity [7][16].

Market Overview - The A-share market experienced a high and then a pullback, with the Shanghai Composite Index barely holding above 4100 points, while major indices like the Shenzhen Component and Northbound 50 closed with small gains but long upper shadows [1] - The market saw active trading, with daily trading volumes frequently hitting historical highs, and weekly trading volume reaching a record 17 trillion yuan [1] Fund Flows - Significant inflows of leveraged funds continued despite market adjustments, with net financing purchases exceeding 91.3 billion yuan for the week, marking a five-month high, and the financing balance reaching 2.7 trillion yuan, setting a new record for nine consecutive days [2] - The computer industry attracted over 12.3 billion yuan in net financing purchases, while electronics and telecommunications received 10.3 billion yuan and over 9 billion yuan, respectively [2] - Major sectors like defense and non-bank financials saw net outflows of over 24.3 billion yuan and 10.8 billion yuan, respectively [2] Chip Sector - The chip sector saw multiple instances of end-of-day buying, with the sector index hitting historical highs in 7 out of the last 10 trading days [3] - Companies like *ST Chengchang and Liou Co. experienced significant price increases, with *ST Chengchang hitting 128.98 yuan per share, the highest price for any ST stock [3] - Reports indicate that major chip manufacturers AMD and Intel have sold out their server CPU production for the year, leading to planned price increases of 10%-15% [3] Power Industry Outlook - The power equipment sector has shown strong performance, with indices for ultra-high voltage, grid equipment, smart grids, and energy storage reaching historical highs [4] - The State Grid announced a fixed asset investment of 4 trillion yuan for the 14th Five-Year Plan, a 40% increase from the previous plan, focusing on technological innovation and new power system construction [4] - Goldman Sachs predicts that investments in global digital infrastructure and energy systems driven by AI could reach 5 trillion dollars over the next decade, with power grid equipment being a primary beneficiary [4]

Group 1 - The core viewpoint of the article highlights the active performance of AI hardware sectors, such as storage chips and CPO, with significant increases in various indices, including a 2.6% rise in the ChiNext Mid-Cap 200 Index and a 1.7% increase in the ChiNext Growth Index [1] - The current market should focus on the dual growth of "technology + cycle," with AI hardware experiencing a surge similar to the previous peak during 5G base station construction, driven by rapid structural demand for AI computing power [1] - The sustained strength of AI hardware is attributed to the marginal changes in profit growth, which have not yet shown a significant turning point, suggesting a continuation of the valuation bull market [1] Group 2 - The ChiNext Index increased by 1.0%, while the ChiNext Mid-Cap 200 Index and ChiNext Growth Index saw increases of 2.6% and 1.7%, respectively, indicating a positive trend in the market [3] - The rolling price-to-earnings (P/E) ratios for the indices are 43.1 times for the ChiNext Index, 116.6 times for the ChiNext Mid-Cap 200 Index, and 41.8 times for the ChiNext Growth Index, reflecting varying levels of valuation across these indices [3] - The ChiNext Mid-Cap 200 Index consists of 200 stocks with medium market capitalization and good liquidity, with over 40% representation from the information technology sector [4]

Market Performance - The Sci-Tech 100 Index increased by 4.5%, the Sci-Tech Composite Index rose by 2.9%, the Shanghai Sci-Tech 50 Component Index went up by 2.6%, and the Shanghai Sci-Tech Growth Index saw a rise of 0.9% this week [1][3]. Industry Developments - A significant breakthrough in the development of new semiconductor materials was achieved by a team from the University of Science and Technology of China, which successfully constructed a programmable, atomically flat "mosaic" heterojunction in two-dimensional ionic soft crystal materials. This technology overcomes the challenges of traditional processes that tend to damage soft crystal structures, paving the way for the development of high-performance light-emitting and integrated devices [1]. Index Composition - The Shanghai Sci-Tech 100 Index consists of 100 stocks with medium market capitalization and good liquidity, focusing on small and medium-sized tech enterprises, with over 80% of its composition in the electronics, biopharmaceuticals, computer, and power equipment sectors [5]. - The Shanghai Sci-Tech Composite Index covers all market securities, focusing on core frontier industries such as artificial intelligence, semiconductors, new energy, and innovative pharmaceuticals, encompassing all 17 primary industries listed on the Sci-Tech Board [5]. - The Shanghai Sci-Tech Growth Index is composed of 50 stocks with high growth rates in revenue and net profit, with over 95% of its composition in high-growth sectors like electronics, power equipment, biopharmaceuticals, and automotive [5]. ETF Tracking - There are currently 19 ETFs tracking the Shanghai Sci-Tech 50 Component Index, 13 ETFs for the Shanghai Sci-Tech 100 Index, 15 ETFs for the Shanghai Sci-Tech Composite Index, and 4 ETFs for the Shanghai Sci-Tech Growth Index, with varying fee rates and tracking errors [5].

1月16日，A股市场整体下跌。截至收盘，上证指数收报4101.91点，下跌0.26%；深证成指收报14281.08点，下跌 0.18%；创业板指收报3361.02点，下跌0.2%。两市合计成交30262.32亿元，较上一交易日增加1207.36亿元。 1.两市主力资金净流出近240亿元 今日沪深两市主力资金开盘净流出106.45亿元，尾盘净流出38.37亿元，全天净流出238.85亿元。 | | | 沪深两市最近五个交易日主力资金流向情况(亿元) | | | | --- | --- | --- | --- | --- | | 日期 | | 净流入金额 开盘净流入 | 尾盘净流入 | 超大单净买入 | | 2026-1-16 | -238.85 | -106. 45 | -38. 37 | -133. 83 | | 2026-1-15 | -509.20 | -225.52 | 49.73 | -265. 38 | | 2026-1-14 | -504.74 | -71.84 | -54. 14 | -90. 16 | | 2026-1-13 | -1286.54 | -530. 96 | -183. 95 | ...

1月16日，A股市场整体下跌。截至收盘，上证指数收报4101.91点，下跌0.26%；深证成指收报14281.08 点，下跌0.18%；创业板指收报3361.02点，下跌0.2%。两市合计成交30262.32亿元，较上一交易日增加 1207.36亿元。 1. 两市主力资金净流出近240亿元 今日沪深两市主力资金开盘净流出106.45亿元，尾盘净流出38.37亿元，全天净流出238.85亿元。 | | | 沪深两市最近五个交易日主力资金流向情况(亿元) | | | | --- | --- | --- | --- | --- | | 日期 | | 净流入金额 开盘净流入 | 尾盘净流入 | 超大单净买入 | | 2026-1-16 | -238.85 | -106. 45 | -38. 37 | -133. 83 | | 2026-1-15 | -509.20 | -225. 52 | 49.73 | -265. 38 | | 2026-1-14 | -504.74 | -71.84 | -54. 14 | -90. 16 | | 2026-1-13 | -1286.54 | -530. 96 | -183. 9 ...

Core Viewpoint - The A-share market is experiencing an increase in performance announcements as the deadline for annual report forecasts approaches, with over 280 companies having disclosed their 2025 annual report forecasts by January 16, representing nearly 5.2% of the total market [1]. Group 1: Performance Forecasts - Nearly half of the disclosed companies have positive performance forecasts for 2025, with around 140 companies (47.6%) expecting an increase, slight increase, turnaround, or continued profit [3]. - The breakdown of positive forecasts includes 26.9% expecting an increase, 14.7% a slight increase, 5.6% a turnaround, and 0.3% continued profit [3]. - Conversely, about half of the companies are expected to incur losses in 2025, with 19.6% continuing losses, 10.5% first-time losses, 8.7% reduced losses, 4.9% increased losses, and 4.5% reduced forecasts [3]. Group 2: Industry Distribution - The sectors with the highest number of companies expecting positive performance include basic chemicals, electronics, automotive, pharmaceutical biology, and machinery, accounting for nearly 56.6% of the positive forecast companies [3]. - In terms of loss forecasts, the sectors with the highest concentration of expected losses are electronics, electrical equipment, construction decoration, machinery, and pharmaceutical biology [4]. Group 3: Individual Company Performance - Among the disclosed forecasts, 11 companies are expected to have a net profit (lower limit) exceeding 5 billion yuan, with Zijin Mining leading at 51 billion yuan [8]. - Other notable companies with significant profit forecasts include Luoyang Molybdenum, Luxshare Precision, WuXi AppTec, Muyuan Foods, and Baofeng Energy, all exceeding 10 billion yuan [8]. - A total of 48 companies are expected to see their profit growth double, with Kewen Biological, Zhongtai Shares, SAIC Motor, and Bawei Storage among the top performers [8]. Group 4: Turnaround Companies - There are 16 companies expected to turn around from losses, with Kewen Biological leading with a projected profit growth of over 10 times [10]. - Other companies with significant turnaround forecasts include Zhongtai Shares, Huazheng New Materials, and Haowu Shares, all showing growth rates above 2 times [10]. - The sectors with the most turnaround companies include machinery, basic chemicals, agriculture, automotive, and others [10].

Core Insights - The average stock price of the Sci-Tech Innovation Board is 48.48 yuan, with 97 stocks priced over 100 yuan, and the highest priced stock is Cambrian-U at 1424.05 yuan [1] - A total of 379 stocks on the Sci-Tech Innovation Board rose today, while 212 stocks fell, with the average price increase for stocks over 100 yuan being 2.55% [1] - The average premium of the latest closing price of stocks over 100 yuan relative to their issue price is 522.15%, with the highest premiums seen in companies like Shunwei New Materials and Anji Technology [1] Stock Performance - Cambrian-U closed at 1424.05 yuan, up 0.64%, followed by Yuanjie Technology at 748.04 yuan and Moer Thread-U at 646.76 yuan [2] - Among the stocks priced over 100 yuan, 70 stocks increased in price today, with notable gainers including Tianyue Advanced and Baiwei Storage [1][2] - The stocks with the largest declines included Hot Scene Biology and Zhaoyi Information, with respective drops of 6.24% and 5.50% [2][3] Capital Flow - The net inflow of main funds into stocks priced over 100 yuan today totaled 3.635 billion yuan, with Cambrian-U, Lanjie Technology, and Huahong Company leading in net inflows [2] - The total margin financing balance for stocks over 100 yuan is 122.632 billion yuan, with Cambrian-U and SMIC having the highest financing balances [2] Industry Distribution - The stocks priced over 100 yuan are concentrated in the electronics, computer, and machinery equipment sectors, with 46, 13, and 11 stocks respectively [1]

Group 1 - A total of 276 companies have announced their annual performance forecasts for 2025, with 111 companies expecting profit increases, accounting for 40.22% [1] - Among the companies with positive forecasts, 52 are expected to have a net profit increase of over 100%, while 33 companies are projected to have an increase between 50% and 100% [1] - The highest expected net profit increase is from Huisheng Biological, with a median increase of 1355.24%, followed by Zhongtai Co. and SAIC Motor with median increases of 677.22% and 498.00% respectively [1] Group 2 - The average increase for companies expected to double their profits this year is 11.80%, outperforming the Shanghai Composite Index [2] - The stock with the highest increase this year is Jinhaitong, which has risen by 43.66%, followed by Baiwei Storage and Baiao Saitu with increases of 36.78% and 30.99% respectively [2] - Companies with significant expected profit increases are concentrated in the electronics, basic chemicals, and pharmaceutical biotechnology sectors, with 8, 7, and 6 companies respectively [1] Group 3 - The list of companies expected to have significant profit increases includes Huisheng Biological, Zhongtai Co., and SAIC Motor, with respective median profit increases of 1355.24%, 677.22%, and 498.00% [2] - Other notable companies include Baiwei Storage with a median increase of 473.71% and Huazheng New Materials with 392.52% [2] - The performance of these companies varies across sectors, with electronics and pharmaceuticals showing strong growth potential [1][2]

Core Insights - The financing balance of the ChiNext market has reached 600.61 billion yuan, marking a continuous increase for nine trading days, with a total increase of 50.47 billion yuan during this period [1] Financing Balance Overview - As of January 15, 2026, the total margin balance of the ChiNext market is 602.50 billion yuan, an increase of 4.94 billion yuan from the previous trading day [1] - The financing balance specifically is 600.61 billion yuan, which is an increase of 4.95 billion yuan from the previous day [1] - The increase in financing balance has been observed in 691 stocks, with 224 stocks showing an increase of over 20% [1] Notable Stocks with Significant Financing Changes - The stock with the highest increase in financing balance is 港通医疗 (Port Medical), with a latest financing balance of 12.12 million yuan, reflecting a 325.93% increase [2] - Other notable stocks include 普蕊斯 (Pruis) and 美好医疗 (Beautiful Medical), with increases of 249.18% and 211.84%, respectively [2] - Conversely, 森鹰窗业 (Sen Ying Window Industry) has the largest decrease in financing balance at 1.47 million yuan, down 33.80% [2] Market Performance - Stocks with a financing balance increase of over 20% have averaged a rise of 19.09%, outperforming the ChiNext index [4] - The top performers include 志特新材 (Zhi Te New Materials), 易点天下 (Easy Point World), and 迪安诊断 (Di An Diagnosis), with increases of 198.57%, 100.79%, and 82.97%, respectively [4] - The largest increase in financing balance by amount is seen in 蓝色光标 (Blue Focus), with a latest balance of 5.83 billion yuan, increasing by 2.92 billion yuan [4] Sector Analysis - Among stocks with financing balance increases over 20%, the majority are concentrated in the computer, electronics, and pharmaceutical industries, with 33, 32, and 31 stocks respectively [3]